Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

It has been shown that virological protease inhibitor (PI) resistance mutations present at the initiation of saquinavir (SQV) plus ritonavir (RTV) therapy in PI-experienced patients are the strongest predictors of virological response. But most of the current resistance algorithms are adapted for un...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Marcelin, Anne-Geneviève, Dalban, Cécile, Peytavin, Gilles, Lamotte, Claire, Agher, Rachid, Delaugerre, Constance, Wirden, Marc, Conan, Françoise, Dantin, Sylvie, Katlama, Christine, Costagliola, Dominique, Calvez, Vincent
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2004
Matèries:	Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC529185/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15561845/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.12.4687-4692.2004
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!